Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Peris

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Medicina Clinica|March 19, 2008
[Whipple's disease. Analysis of 6 cases]Raquel Reyes, Pilar Peris, Faust Feu, et al.
Medicina Clinica|September 29, 2009
[Relationship between C-telopeptides of type I collagen serum values with bone mineral density and antiosteoporotic drug intake in postmenopausal women. Preliminary data from the FRODOS study]Eduardo Kanterewicz, Emma Puigoriol, Pilar Peris, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 29, 2023
Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fracturesPilar Peris, Jordi Blasco, Ana Monegal, et al.
Clinical Rheumatology|March 28, 2006
Camptocormia as a clinical manifestation of mitochondrial myopathyJosé A Gómez-Puerta, Pilar Peris, Josep M Grau, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosisNúria Guañabens, Anna Monegal, Dacia Cerdá, et al.
Gastroenterology|February 25, 2010
Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosisNúria Guañabens, Dacia Cerdá, Ana Monegal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2007
Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone diseaseAna Monegal, Miquel Navasa, Pilar Peris, et al.
The American Journal of the Medical Sciences|March 12, 2010
Effects of intravenous pamidronate on renal function, bone mineral metabolism and bone mass in patients with severe osteoporosisMa Victoria Hernández, Pilar Peris, Ana Monegal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 5, 2020
Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosisSilvia Ruiz-Gaspà, Núria Guañabens, Susana Jurado, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 15, 2005
Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bonePeter Alexandersen, Pilar Peris, Nuria Guañabens, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Medicina Clinica|March 19, 2008
[Whipple's disease. Analysis of 6 cases]Raquel Reyes, Pilar Peris, Faust Feu, et al.
Medicina Clinica|September 29, 2009
[Relationship between C-telopeptides of type I collagen serum values with bone mineral density and antiosteoporotic drug intake in postmenopausal women. Preliminary data from the FRODOS study]Eduardo Kanterewicz, Emma Puigoriol, Pilar Peris, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 29, 2023
Effect of gender on the evolution of pain and quality of life after treatment of symptomatic vertebral fragility fracturesPilar Peris, Jordi Blasco, Ana Monegal, et al.
Clinical Rheumatology|March 28, 2006
Camptocormia as a clinical manifestation of mitochondrial myopathyJosé A Gómez-Puerta, Pilar Peris, Josep M Grau, et al.
Hepatology (Baltimore, Md.)|May 21, 2013
Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosisNúria Guañabens, Anna Monegal, Dacia Cerdá, et al.
Gastroenterology|February 25, 2010
Low bone mass and severity of cholestasis affect fracture risk in patients with primary biliary cirrhosisNúria Guañabens, Dacia Cerdá, Ana Monegal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2007
Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone diseaseAna Monegal, Miquel Navasa, Pilar Peris, et al.
The American Journal of the Medical Sciences|March 12, 2010
Effects of intravenous pamidronate on renal function, bone mineral metabolism and bone mass in patients with severe osteoporosisMa Victoria Hernández, Pilar Peris, Ana Monegal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 5, 2020
Bilirubin and bile acids in osteocytes and bone tissue. Potential role in the cholestatic-induced osteoporosisSilvia Ruiz-Gaspà, Núria Guañabens, Susana Jurado, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 15, 2005
Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bonePeter Alexandersen, Pilar Peris, Nuria Guañabens, et al.
Pageof 9